| Serial Number | 88711676 |
| Word Mark | ESSENCA |
| Filing Date | Monday, December 2, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, December 12, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 15, 2020 |
| Goods and Services | Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical testing kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances examined in bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Medicines for medical and veterinary purposes for cancers, blood abnormalities, immune disease, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Medical diagnostic reagents and assays for testing bodily fluids for the prevention of disease in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic reagents and assays for testing bodily fluids for monitoring and testing illnesses and disorders in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases |
| Pseudo Mark | ESSENCE |
| Goods and Services | Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, namely, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, and diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use |
| Translation of Words in Mark | The wording "ESSENCA" has no meaning in a foreign language. |
| Goods and Services | Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Nutrition counseling; Healthcare services in the field of digital healthcare services, namely, the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing wellness information in the nature of providing information in the fields of health and wellness; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes; Health monitoring services, namely, monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Disease prevention services, namely, medical screening and testing services for preventing diseases in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Medical and healthcare services for monitoring and testing illnesses and disorders in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases |
| Goods and Services | Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and health monitoring devices that detect health conditions and diseases in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes; Medical diagnostic instruments for the analysis of body fluids in the nature of biological and chemical test kits for the detection and identification of nucleic acids, namely, DNA and RNA in a sample; Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, nucleic acids, and nucleotides for the prevention of disease in the nature of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 6, 2019 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 6, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 6, 2019 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, December 6, 2019 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Essenlix Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Monmouth Junction, NJ 08852 |
| Party Name | Essenlix Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Monmouth Junction, NJ 08852 |
| Event Date | Event Description |
| Monday, December 12, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, December 12, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Thursday, May 26, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, May 25, 2022 | SOU EXTENSION 3 GRANTED |
| Tuesday, May 10, 2022 | SOU EXTENSION 3 FILED |
| Tuesday, May 24, 2022 | NOTICE OF REVIVAL - E-MAILED |
| Monday, May 23, 2022 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Monday, May 23, 2022 | PETITION TO REVIVE-GRANTED |
| Monday, May 23, 2022 | TEAS PETITION TO REVIVE RECEIVED |
| Friday, January 14, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 13, 2022 | SOU EXTENSION 2 GRANTED |
| Wednesday, November 10, 2021 | SOU EXTENSION 2 FILED |
| Tuesday, January 11, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, November 16, 2021 | NOTICE OF REVIVAL - E-MAILED |
| Tuesday, November 16, 2021 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Tuesday, November 16, 2021 | PETITION TO REVIVE-GRANTED |
| Tuesday, November 16, 2021 | TEAS PETITION TO REVIVE RECEIVED |
| Tuesday, May 11, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, May 7, 2021 | SOU EXTENSION 1 GRANTED |
| Friday, May 7, 2021 | SOU EXTENSION 1 FILED |
| Friday, May 7, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 10, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, September 15, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 15, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 26, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, August 13, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, August 11, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 11, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Sunday, August 9, 2020 | ASSIGNED TO LIE |
| Wednesday, July 22, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 22, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 22, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 22, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, January 14, 2020 | ASSIGNED TO EXAMINER |
| Friday, December 6, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, December 5, 2019 | NEW APPLICATION ENTERED |